PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹559 Cr | ₹559 Cr | ₹460 Cr | ₹661 Cr | ₹625 Cr |
What is the latest Revenue of PANACEA BIOTEC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹559 Cr |
| Mar2024 | ₹559 Cr |
| Mar2023 | ₹460 Cr |
| Mar2022 | ₹661 Cr |
| Mar2021 | ₹625 Cr |
How is Revenue of PANACEA BIOTEC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹559 Cr | -0.01 | |
| Mar2024 | ₹559 Cr | 21.57 | |
| Mar2023 | ₹460 Cr | -30.44 | |
| Mar2022 | ₹661 Cr | 5.83 | |
| Mar2021 | ₹625 Cr | - | |
Compare Revenue of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,334.6 Cr | -4.2% | 9% | -9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -4.2% |
9% |
-9.5% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses